{"name":"KoBioLabs","slug":"kobiolabs","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFA4ejZmWV9wbjV4RW9lLTRyMVRmSVBLUmtKODlyTkZmeGxsNUloMFlHNU12ODBTd3ZXSkVJVUNyNGRxTUFrVU5XdlZXWWNiZlVrRmxTcF9nSHdNOVNKWUpOY09aS1p2MXI4V0loRXhR0gFyQVVfeXFMTldwSm9NaS1vRndpbmNobnVNUGdHYXJxUHJlcEFJSmhkZ0E1SDJzdFo1VnpZaE1QczJrc2RkVmh0NG4wek91U2l5SFFvWllmaXJKbE9GLVVYRGpWLWNxT0tNd2txVDFpd1duWmxTZ3NFMktR?oc=5","date":"2026-03-25","type":"deal","source":"koreabiomed.com","summary":"Celltrion signs microbiome drug licensing deal with KoBioLabs worth up to ₩205.2 billion - koreabiomed.com","headline":"Celltrion signs microbiome drug licensing deal with KoBioLabs worth up to ₩205.2 billion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxQdUVnN01KRmpOTHJSdmFMUUM3UEFrTldYRXZyOV95b3R4MVE1NGR4cTdzLUJscWxXNFZIXy00djhVdXVRbk83RThoV0k4VjAxQkhfYTBLVENWUnpUMkx3U0lfREhTbzB5MTcyUTlxZXdjZG5td3ZGRHZRQnE1RHpkQtIBlAFBVV95cUxPUmxtbXh4Y3lfUjR6UXY2eUEtN2lNd01wV1RqdVE4QzVZZlpYTUVtSmw5SEgyQWNBUlA5MUpBcnZvUUdXZUtzNHplY2t0NVlHWHlLVGtqWllJdmlnNC1xTnZTUHdJX21lU0ZESlpqTHFfOTFNSTIxNUgxRmFKMW1lV0tQd04yQ2pxcTRmdkF0WHdDdjFY?oc=5","date":"2026-01-04","type":"pipeline","source":"Chosunbiz","summary":"Korean microbiome developers halt drug programs and pivot to cosmetics and supplements - CHOSUNBIZ - Chosunbiz","headline":"Korean microbiome developers halt drug programs and pivot to cosmetics and supplements - CHOSUNBIZ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE9kTzFTbW1yRDFGbC1yMHU1RHM3TFhuSnhySUxVNTdOb1NQME9IaTY1Y09YM3Naam9DNm1MQnFHRE9IaEJ5VFlKUV9iMUl4bHY1TVNuYXR2NjlQYnJlRTl0N1Y5SkdLX0pfQzJPVzRB?oc=5","date":"2025-09-03","type":"patent","source":"팜이데일리","summary":"KoBioLabs Wins U.S. Patent for Natural GLP-1 Obesity Therapy[K-Bio Pulse] - 팜이데일리","headline":"KoBioLabs Wins U.S. Patent for Natural GLP-1 Obesity Therapy[K-Bio Pulse] - 팜이데일리","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxQV2Mzd3U4MDJLX25lZGxDTUxoTmpKSGx4VEhMWlhWYTRMVjRHTFhDM1lwRjhyWVlzWVpjcEl2VnFjSVptVUZvaWFwVFpkeURjVEdzc3VXUFFJYWdiMEZnazRKUjFiT0VSaktGN09BMGhRc0xhTkxiUU5HQi1Vb0ZqLTUwV19QY0tmeWNLalBHSmVlZDJwUVRQT2s3SmZjbXNWR3FDMTJiNm1rSGJuYklFcEtnOVRrSF8wa29RWFhKZ3g1d0ZYQ1dn?oc=5","date":"2025-07-01","type":"regulatory","source":"Healio","summary":"Latest from FDA: Zoryve foam, more psoriasis biosimilars, Keytruda for skin cancer - Healio","headline":"Latest from FDA: Zoryve foam, more psoriasis biosimilars, Keytruda for skin cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwJBVV95cUxNMVBaRmxTUlZYYlVWSDVjcTktZFljZjFfcE9VbDlMR29mYUNmdGhENU1KMTRoVG1NcnVtUVphMnJuMXB0V0tCb1ZGVFZIOVFPMDBjQ3NNTC1ETWdnOFJGTy12Y2VJM1VLbDZzYlQ0bmlGRlhBb0Y0dlpPZ2hwb213TW01Z1RETzBBTU9vbFdtcjhaZHdMZERpbWlRQ0dCa2c1SVB2MXVkWjJrSXk5V0Z4Z1VneTlreEFEX0h2dW54NGpnRGt0a29fLW5xZEZoMDg4V0dDRGhvMDV1Q3hmQTlNcmJieVBmTEdoRXlvZ0hvcXdqbDdFazdMSGEwSU4yQkFGdVg4R1Nla3lXQ19hOUtwX0lJZVlBLTFVQkpF?oc=5","date":"2024-07-15","type":"regulatory","source":"PR Newswire","summary":"SKYRIZI's Approval For Ulcerative Colitis Treatment Expands AbbVie's Portfolio Across Immune-mediated Inflammatory Diseases | DelveInsight - PR Newswire","headline":"SKYRIZI's Approval For Ulcerative Colitis Treatment Expands AbbVie's Portfolio Across Immune-mediated Inflammatory Disea","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFA1ZkR0V0NUV1k4U0k0dEFKVUpsRWt1RHRmRjY1bGktOGFSczVtcURlR19wb2t4bUpON012WFQxQ01VdEJqcHZtSjJHb01sUWFTZFdSY1lMYUZheF9aSnpfLVF4cWg0QU9YY053ZUVn?oc=5","date":"2024-01-10","type":"patent","source":"KED Global","summary":"Kobiolabs gets US patent for oral obesity drug candidate - KED Global","headline":"Kobiolabs gets US patent for oral obesity drug candidate","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE5iVHVoR1VIcVJ2U3BodnQ3QlVJcnU0V3V0SHBZa2tVNmE0ZWlURTV3cEVDYlNKcnpQUWlzR2QteGVBYXdjZjRsUFp6a0pvM2lBUkY4azZTTmRvYWViNXkwN0drR0I1NU00RWdwaGNB0gFyQVVfeXFMTUZWUDdleG1pUWdsWnBVdFVKN2VmVGRrd1p4RUpDVVdkaWJFOXE0dWsyZjFzTkhwaDRET2lXVlpRNE0xNFZaSzhYTG91NmdhT2JsWnN0ZkxfSGlOU2ROTlBoZDZwNEpQd2pXTlIxYXpRR0dB?oc=5","date":"2023-07-13","type":"pipeline","source":"koreabiomed.com","summary":"Bioplus-Interphex 2023: Korea launches business council to boost microbiome competitiveness - koreabiomed.com","headline":"Bioplus-Interphex 2023: Korea launches business council to boost microbiome competitiveness","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}